Ira Thabrew

Ira Thabrew

Auto-generated profile, based on publicly available information

Ira Thabrew

Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, No. 90, Cumaratunga Munidasa Mawatha, Colombo 03, Sri Lanka

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LTLuxmiga Tharmarajah
Luxmiga Tharmarajah
SSSameera Samarakoon
Sameera Samarakoon
MEMeran Ediriweera
Meran Ediriweera
PPPoorna Piyathilaka
Poorna Piyathilaka
KTKamani Tennekoon
Kamani Tennekoon
ITIra Thabrew
Ira Thabrew
Gedunin is one of the major compounds found in the neem tree(Azadirachta indica). In the present study, antiproliferative potential of gedunin was evaluated in human embryonal carcinoma cells (NTERA-2, a cancer stem cell model) and peripheral blood mononuclear cells (PBMCs), using Sulforhodamine (SRB) and WST-1 assays, respectively. The effects of gedunin on expression of heat shock protein 90 (HSP90), its cochaperone Cdc37, and HSP client proteins (AKT, ErbB2, and HSF1) were evaluated by real-time PCR. Effects of gedunin on apoptosis were evaluated by (a) apoptosis associated morphological changes, (b) caspase 3/7 expression, (c) DNA fragmentation, (d) TUNEL assay, and (e) real-time PCR of apoptosis related genes (Bax,p53,andsurvivin). Gedunin showed a promising antiproliferative effect in NTERA-2 cells with IC50values of 14.59, 8.49, and 6.55 μg/mL at 24, 48, and 72 h after incubations, respectively, while exerting a minimal effect on PBMCs. Expression of HSP90, its client proteins, andsurvivinwas inhibited andBaxandp53were upregulated by gedunin. Apoptosis related morphological changes, DNA fragmentation, and increased caspase 3/7 activities confirmed the proapoptotic effects of gedunin. Collectively, results indicate that gedunin may be a good drug lead for treatment of chemo and radiotherapy resistant cancer stem cells.

24 July 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
NSNivethika Sivakumaran
Nivethika Sivakumaran
SSSameera Samarakoon
Sameera Samarakoon
AAAchyut Adhikari
Achyut Adhikari
MEMeran Ediriweera
Meran Ediriweera
KTKamani Tennekoon
Kamani Tennekoon
RSRam Lal (Swagat) Shrestha
Ram Lal (Swagat) Shrestha
Current breast cancer therapies have limitations in terms of increased drug resistance resulting in short-term efficacy, thus demanding the discovery of new therapeutic agents. In this study, cytotoxic activity and apoptotic effects of govaniadine isolated fromCorydalis govanianaWall. roots were determined on human breast cancer (MCF-7) cells. The SRB assay result revealed that govaniadine led to dose- and time-dependent cytotoxic effect in MCF-7 cells along with less cytotoxicity against MCF-10A cells. Govaniadine-induced apoptosis was also accompanied by upregulation ofBax,p53, andSurvivinmRNA expression as assessed by real time PCR analysis. Flow cytometric analysis with Annexin V and PI staining indicated that govaniadine is a potent inducer of apoptosis in MCF-7 cell lines. Distinctive morphological changes contributed to apoptosis and DNA laddering were observed in govaniadine-treated MCF-7 cells. Caspase-7 was significantly activated in treated MCF-7 cells. Govaniadine-treated MCF-7 cells also showed enhanced levels of intracellular reactive oxygen species (ROS) and glutathione S-transferase (GST) and decreased levels of glutathione (GSH). The results indicate that govaniadine has potent and selective cytotoxic effects against MCF-7 cells and the potential to induce caspase 7 dependent apoptosis in MCF-7 cells by activation of pathways that lead to oxidative stress.

19 December 2019 in Stem Cells International
Verified
Journal Article
Open access
PDF file
NANuwanka K. Abeysinghe
Nuwanka K. Abeysinghe
ITIra Thabrew
Ira Thabrew
SSSameera Samarakoon
Sameera Samarakoon
MEMeran Ediriweera
Meran Ediriweera
KTKamani Tennekoon
Kamani Tennekoon
AMAnuka S. Mendis
Anuka S. Mendis
Vernonia zeylanica, is a shrub endemic to Sri Lanka. V. zeylanica has been used in Sri Lankan traditional medicine for the treatment of various diseases and conditions. The present study was designed to determine antiproliferative, apoptotic, autophagic, and antioxidant effects of vernolactone, isolated from V. zeylanica, in human embryonal carcinoma cells (NTERA-2, a cancer stem cell model). Antiproliferative effects of vernolactone in NTERA-2 cells and human peripheral blood mononuclear cells (control cells) were evaluated using the Sulforhodamine B (SRB) assay and WST-1 antiproliferative assays, respectively. The antiproliferative effect of vernolactone was further investigated using the colony formation assay. Effects of vernolactone on apoptosis were investigated by phase contrast light microscopic and fluorescence microscopic analysis, caspase 3/7 expression, and real-time PCR of apoptosis-associated genes p53 and Survivin. The effect of vernolactone on NTERA-2 cell migration was monitored using the wound healing assay. Effects of vernolactone on the expression of autophagy-related genes (LC3, Beclin 1, PI3K, Akt, and mTOR) were evaluated using real-time PCR. 2,2-Diphenyl-1-2,2-diphenyl-picrylhydrazyl (DPPH) radical scavenging assay, 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging, and ferric reducing antioxidant power (FRAP) assays were also carried out to evaluate the antioxidant activity of vernolactone. Overall results confirm that vernolactone can exert antiproliferative effects, induce apoptosis and autophagy, and decrease NTERA-2 cell migration in a dose- and time-dependent manner with a very small antioxidant property.